Associated Papers
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial.
Rose AAN et al.
Nature Communications, 2026
41484121 (PubMed )
Supplement: 41467_2025_68076_MOESM1_ESM.pdf
Small Molecule B-RAF Inhibitors as Anti-Cancer Therapeutics: Advances in Discovery, Development, and Mechanistic Insights.
Anaya YA et al.
International Journal of Molecular Sciences, 2025
Targeting oncogenic Raf protein-serine/threonine kinases in human cancers.
Roskoski R
Pharmacological Research, 2018
BRAF mutations in non-small cell lung cancer: has finally Janus opened the door?
Caparica R et al.
Critical Reviews in Oncology/hematology, 2016
Select a paper to view details